Skip to main content

Malignant Neoplasm of Breast clinical trials at UCSF
1 in progress, 1 open to new patients

  • Targeted Intraoperative Radiotherapy United States (TARGIT-US) Registry Trial

    open to eligible females ages 45 years and up

    This study proposes to study the efficacy and toxicity of breast radiotherapy given intra-operatively as a single dose after breast conserving surgery, with or without whole breast radiation as indicated by pathologic risk factors, in women with early stage breast cancer.

    San Francisco, California and other locations